Skip to main content
Premium Trial:

Request an Annual Quote

Althea Technologies Granted Patent for Gene Expression Profiling Technology

NEW YORK Sept. 15 (GenomeWeb News) – Althea Technologies of San Diego said today it has been granted a US patent covering its “eXpress” PCR-based gene expression profiling technology.

The patent, No. 6,618,679, is entitled “Methods for Analysis of Gene Expression,” was granted Sept, 9. It covers not only methods, but also kits to enable gene expression profiling, as well as collection of gene expression data and relational data analysis. The methods, according to the patent “are highly highly sensitive; have a wide dynamic range; are rapid and inexpensive; have a high throughput; and allow the simultaneous differential analysis of a defined set of genes.”

The eXpress technology uses rtPCR to monitor tens to hundreds of genes at a time, the company said, and can be used with as little as several nanograms of total RNA and off-the shelf reagents.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.